Chemical Compound

1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B

CAS Registry Number 13553-79-2
1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B 结构式
Primary record

1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B

库存
9,878 克
纯度
99.4 %
CAS
13553-79-2

化合物标识与属性

CAS
13553-79-2
PubChem CID
6436726
SMILES
C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=O)C3=C(C2=O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)/C
Canonical SMILES
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)C=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O

名称与同义词

  • Rifamycin S
  • Rifomycin S
  • Rifampicin S
  • rifamycin-S
  • Rafamycin S
  • Rifamycin S CRS
  • 13553-79-2
  • Rifaximin EP Impurity E
  • RefChem:179427
  • GlyTouCan:G05123TM
  • PI53N820JV
  • UNII-PI53N820JV
  • RIFAMYCIN S [MI]
  • MFCD06198807
  • NSC 144130
  • SCHEMBL415695
  • EINECS 236-938-4
  • BTVYFIMKUHNOBZ-ODRIEIDWSA-N
  • NCI 144-130
  • C37H45NO12
  • CHEMBL236921
  • DTXSID301043935
  • SCHEMBL29618023
  • CHEBI:34948
  • 1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin
  • BRN 0604802
  • RIFAMYCIN S [EP IMPURITY]
  • DTXCID601526374
  • 1,4-Dideoxy-1,4-dioxo-rifamycin
  • NSC-144130
  • G05123TM
  • MSK15202
  • BBF-02633
  • NSC144130
  • s4425
  • C37-H45-N-O12
  • ZINC169660600
  • CID6436726
  • CS-O-02278
  • Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-
  • AN-15577
  • FR151216
  • LS-64233
  • SC-19209
  • SY235204
  • 1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin
  • RIFAXIMIN IMPURITY E [EP IMPURITY]
  • FT-0654816
  • A11758
  • C14540
  • 553R792
  • RIFAMYCIN SODIUM IMPURITY B [EP IMPURITY]
  • A1200356
  • Q27116328
  • (trihydroxy-methoxy-heptamethyl-tetraoxo-[?]yl) acetate
  • [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate
  • 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
  • ((2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17,19-TRIHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,6,9,11-TETRAOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENAZANO)NAPHTHO(2,1-B)FURAN-21-YL ACETATE
  • ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl) acetate
  • 1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI)
  • 236-938-4